在SARS-CoV-2感染后的二次多发性肌痛性风湿症.
Kazuki Ocho1, Hideharu Hagiya2, Hisashi Ishikawa1
1Department of Internal Medicine, Ishikawa Hospital.
Acta medica Okayama
|December 24, 2024
概括
新型冠状病毒疾病2019 (COVID-19) 可能引发多肌痛性风湿症 (PMR),一种自身免疫性疾病. 用普雷迪尼索隆及时治疗有效地控制了患者的症状,这表明SARS-CoV-2感染和PMR发作之间存在联系.
科学领域:
- 类风湿病学 类风湿病学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 多发性肌痛性风湿症 (PMR) 是一种炎症性疾病,通常影响50岁以上的人.
- PMR的病因通常是特异性的,但人们怀疑病毒触发因素.
- SARS-CoV-2 的出现引发了关于它可能引发自身免疫反应的疑问.
相关概念视频
Myasthenia Gravis: Overview and Treatment
934
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
934
Myasthenia Gravis: Diagnostic Tests
530
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
530


